Has Ho Sun Suh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,327 in general payments to Ho Sun Suh, MD across 414 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ho Sun Suh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ho Sun Suh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ho Sun Suh, MD

Family Medicine · Bellevue, WANPI 1407878416

Payments from drug & device makers

$12,327in general payments, 2019–2025

Across 414 payments — averaging $29.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neuronetics, Inc.$3K
AbbVie$3K
Lilly USA, LLC$703
Antares Pharma, Inc.$666
Amgen$532
Takeda Pharmaceuticals U.S.A., Inc.$529
plus $5K from 46 others

What the payments were for

Travel & lodging$1,75514%
Food & beverage$10,57286%
Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neuronetics, Inc.	8	$2,606
AbbVie(2 entities)	105	$2,594
Lilly USA, LLC	27	$703
Antares Pharma, Inc.	46	$666
Amgen(2 entities)	18	$532
Takeda Pharmaceuticals U.S.A., Inc.	28	$529
Teva Pharmaceuticals USA, Inc.	17	$490
Biohaven Pharmaceuticals, Inc.	15	$346
Gilead	5	$309
Ironshore Pharmaceuticals Inc.	4	$242
Bausch Health US, LLC	11	$227
Jazz Pharmaceuticals Inc.	8	$220
Pfizer	9	$217
Indivior Inc.	11	$213
AstraZeneca	6	$212
Novo Nordisk	9	$208
Novartis	8	$158
Zimvie Inc.	1	$148
Aimmune Therapeutics, Inc.	6	$148
Corium, LLC	5	$139
Biohaven Pharmaceutical Holding Company Ltd.	6	$135
Amarin Pharma, Inc.	7	$115
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$114
Johnson & Johnson(2 entities)	4	$103
Exact Sciences	3	$90
Phadia US Inc.	3	$77
Zyla Life Sciences, Inc.	5	$72
Upsher-smith Laboratories LLC	3	$59
Relievant Medsystems, Inc.	1	$51
MDD US Operations, LLC	3	$51
Abbott	2	$43
Verity Pharmaceuticals Inc.	2	$40
Kowa Pharmaceuticals America, Inc.	2	$38
Halozyme Inc	2	$35
ANI Pharmaceuticals, Inc.	1	$34
Lupin Inc.	2	$30
Vertex	1	$29
Braeburn Inc.	1	$28
Linus Health, Inc.	1	$28
Edwards Lifesciences	1	$27
GSK	1	$24
Si-bone, Inc.	1	$22
Echosens North America, Inc.	1	$21
Collegium Pharmaceutical, Inc.	1	$21
Solta Medical, A Division Of Bausch Health US, LLC	1	$20
Idorsia Pharmaceuticals US Inc	1	$19
Shire North American Group Inc	1	$19
Therapeuticsmd, Inc.	1	$18
Xeris Pharmaceuticals, Inc.	1	$16
Redhill Biopharma Inc.	1	$15
Adlon Therapeutics L.p.	1	$14
BD	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEUROSTAR TMS THERAPY SYSTEM$2,477
Jornay PM 20mg capsules (Bottle of 100)$154
Mobi-C$148
KRYSTEXXA$135
AJOVY$125
Truvada$125
MOUNJARO$124
Yeztugo$122
Creon$122
NURTEC ODT$121
BOTOX COSMETIC$117
FASENRA$110
BOTOX$102

How this compares

$12,327 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington →

Medicare billing

Part B allowed, 2024

$32,511

Medicare patients

Services billed

5,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine Hcl	11	$5,147
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	12	$660
Albuterol Sulfate HfaAlbuterol Sulfate	15	$637
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	23	$615
Rosuvastatin Calcium	34	$530
Alprazolam	54	$463
Omeprazole	23	$460
ValacyclovirValacyclovir Hcl	15	$423
Atorvastatin Calcium	32	$415
Levothyroxine Sodium	21	$354
Bupropion XlBupropion Hcl	11	$311
Losartan Potassium	40	$272
Tamsulosin Hcl	19	$196
Allopurinol	24	$191
Metformin Hcl	15	$186

Paid to pharmacies, not to this prescriber.

Other family medicine in Bellevue

Gaylon KippBellevue$4.8M
Andrew AppelbaumBellevue$16K
Anton GraschWenatchee$5.3M
Steven KasterWenatchee$4M
Angela EakinSpokane$3M
Jonathan StabenCheney$2.5M
Emily ZaragozaSeattle$1.9M
Brad FrandsenPort Orchard$1.7M
Kevin HatfieldSeattle$527K
Steven SmithAuburn$438K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →